MCRB vs SPG · rev $1.1M vs rev $3.55B
Seres Therapeutics Inc (MCRB) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
MCRB currently screens at market cap $109.8M. SPG currently screens at market cap $0.
Not investment advice. Open the MCRB and SPG stock pages for the full models.
Not investment advice.